Clinical trials
Completed Diabetes Mellitus, Type 1 trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
71 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 6 |
| 2003 | 2 |
| 2004 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 8 |
| 2013 | 3 |
| 2014 | 6 |
| 2015 | 7 |
| 2016 | 6 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 71 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 18 |
| Radboud University Medical Center | 11 |
| Sanofi | 5 |
| Medical Research Foundation, The Netherlands | 4 |
| Abbott Diabetes Care | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2 |
| Amsterdam UMC, location VUmc | 2 |
| Boehringer Ingelheim | 2 |
| Inreda Diabetic B.V. | 2 |
| J.H. DeVries | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 71 |
| Diabetes Mellitus | 22 |
| Diabetes Mellitus, Type 2 | 11 |
| Hypoglycemia | 5 |
| Insulin Resistance | 3 |
| Glucose Metabolism Disorders | 2 |
| Inflammation | 2 |
| Autoimmune Diseases | 1 |
| COVID-19 | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.